Dermata Therapeutics Inc. Gains 46.84%
Dermata Therapeutics Inc. (DRMA:NASDAQ) soared at $2.32, representing a gain of 46.8%. On Fri, Sep 13, 2024, DRMA:NASDAQ touched a New 2-Week Intraday High of $1.74. The stock got featured on our News Catalysts scanner on Fri, Sep 06, 2024 at 04:34 AM in the 'MISCELLANEOUS' category. From Tue, Sep 03, 2024, the stock recorded 37.50% Up Days and 33.33% Green Days
The stock spiked on Wed, Jul 24, 2024 at $5 with a volume of 65M+, and its share price has been moving sideways in recent weeks.
About Dermata Therapeutics Inc. (DRMA:NASDAQ)
Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.
Top 10 Gainers:
- Calithera Biosciences, Inc. (CALA:NASDAQ), 212.5%
- NuCana plc (NCNA:NASDAQ), 150.79%
- Kubient Inc. (KBNT:NASDAQ), 100%
- NextPlay Technologies Inc. (NXTP:NASDAQ), 76.92%
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 46.84%
- REE Automotive Ltd. (REE:NASDAQ), 44.19%
- Immuneering Corporation (IMRX:NASDAQ), 42.08%
- MKDWELL Tech Inc. (MKDW:NASDAQ), 36.75%
- Coffee Holding Co., Inc. (JVA:NASDAQ), 35.94%
- Li-Cycle Holdings Corp. (LICY:NYSE), 34.21%